Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Jasper Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Mondelēz International to Participate in Barclays Global Consumer Staples Conference on September 3, 2025
-
dLocal announces appointment of Chief Financial Officer
-
dLocal Reports 2025 Second Quarter Financial Results
-
SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
Alumis Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Codexis Reports Second Quarter 2025 Financial Results
-
Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndr
-
Noodles & Company Announces Second Quarter 2025 Financial Results
-
Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update
-
Aqua Metals Advances Commercialization of AquaRefining™ Technology with Industry-Leading Lithium Quality and Strategic Progress During Second Quarter of 2025
-
Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results
-
Global Crossing Airlines Reports Second Quarter 2025 Financial Results
-
Barfresh Announces Second Quarter 2025 Results
-
AirJoule Technologies Announces Second Quarter 2025 Results
-
Five Below, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call Date
-
Fossil Group, Inc. Announces ABL Refinancing and Transaction Support Agreement for Debt Exchange
-
Highview Merger Corp. Announces Completion of $230,000,000 Initial Public Offering
-
Hyperfine, Inc. Reports Second Quarter 2025 Financial Results
-
STRATA Skin Sciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
-
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
-
The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance
-
Coherent Corp. Reports Fourth Quarter and Full Year Fiscal 2025 Results
-
HeartCore Reports Financial Results for Second Quarter and Six Months Ended June 30, 2025
-
Roadzen Reports Best Fiscal Q1 in Company History with 22% Revenue Growth, 92% Lower Net Loss, and 50% Adjusted EBITDA Improvement Over the Same Quarter Last Year
-
Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update
-
Expion360 Reports Second Quarter 2025 Financial and Operational Results
-
Robinhood Markets, Inc. Reports July 2025 Operating Data
-
Dynagas LNG Partners LP Announces Cash Distribution for the Quarter Ended June 30, 2025 of $0.049 Per Unit
-
The Oncology Institute Announces Changes to Board of Directors
-
Xos Hits New Milestones in Q2 2025 with Highest Revenue and Deliveries in the Company’s History
-
Epsilon Announces Second Quarter 2025 Results and Transformative Acquisitions in the Powder River Basin
-
Epsilon Announces Second Quarter 2025 Results and Transformative Acquisitions in the Powder River Basin
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HanesBrands Inc. (NYSE - HBI), Sapiens International Corporation N.V. (Nasdaq – SPNS), American Woodmark Corp
-
Destination XL Group, Inc. to Announce Second Quarter 2025 Financial Results on Wednesday, August 27, 2025
-
Real Estate Expert Sabre Cofer Shares Key Advice on Buying a Home in Amarillo, As Written in HelloNation
-
Conifer Holdings Reports 2025 Second Quarter Financial Results
-
Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress
-
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
-
Elcora Provides Update on Status of Management Cease Trade Order
-
Coherent Announces Agreement to Sell Aerospace and Defense Business to Advent for $400 Million
-
Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results
-
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
-
Coherent Announces Agreement to Sell Aerospace and Defense Business to Advent for $400 Million
-
Birchcliff Energy Ltd. Announces Q2 2025 Results, Strong New Well Performance and Declares Q3 2025 Dividend
-
All Talentz Showcases Global Outsourcing Excellence at SHRM 2025 Conference in San Diego
-
Intuitive Machines Announces Proposed Private Offering of Convertible Senior Notes
